Katsuhiko Imai

Katsuhiko Imai

Auto-generated profile, based on publicly available information

Katsuhiko Imai

Heart Center, NHO Kure Medical Center, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2022 in EP Europace
Verified
Journal Article
Open access
PDF file
ASAvi Sabbag
Avi Sabbag
BEBenjamin Essayagh
Benjamin Essayagh
JBJuan David Ramírez Barrera
Juan David Ramírez Barrera
CBCristina Basso
Cristina Basso
ABAna Berni
Ana Berni
PLPatrizio Lancellotti
Patrizio Lancellotti
Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in patients with MVP, involving two phases based on the clinical and imaging context and the uncovered arrhythmia. In the absence of ventricular tachycardia, phenotypic risk features will trigger the intensity of screening for arrhythmia. Green boxes indicate green heart consensus statements and yellow boxes indicate yellow heart consensus statements. High risk - sustained VT, polymorphic NSVT, fast (>180 bpm) NSVT, VT/NSVT resulting in syncope. ICD = implantable cardioverter defibrillator; LA = left atrium; LGE = late gadolinium enhancement; LV-EF = left ventricular ejection fraction; MAD = mitral annular disjunction; MV = mitral valve; PVCs = premature ventricular contractions; TWI = T-wave inversion; VT = ventricular tachycardia. #Additional ECG monitoring method may be used such as loop recorders.

4 December 2017 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
HMHiroya Matsumura
Hiroya Matsumura
YNYukiko Nakano
Yukiko Nakano
HOHidenori Ochi
Hidenori Ochi
YOYuko Onohara
Yuko Onohara
ASAkinori Sairaku
Akinori Sairaku
YKYasuki Kihara
Yasuki Kihara
A common SCN5A polymorphism H558R (c.1673 A > G, rs1805124) improves sodium channel activity in mutated channels and known to be a genetic modifier of Brugada syndrome patients (BrS). We investigated clinical manifestations and underlying mechanisms of H558R in BrS. We genotyped H558R in 100 BrS (mean age 45 ± 14 years; 91 men) and 1875 controls (mean age 54 ± 18 years; 1546 men). We compared clinical parameters in BrS with and without H558R (H558R+ vs. H558R- group, N = 9 vs. 91). We also obtained right atrial sections from 30 patients during aortic aneurysm operations and compared SCN5A expression and methylation with or without H558R. H558R was less frequent in BrS than controls (9.0% vs. 19.2%, P = 0.028). The VF occurrence ratio was significantly lower (0% vs. 29.7%, P = 0.03) and spontaneous type 1 ECG was less observed in H558R+ than H558R- group (33.3% vs. 74.7%, P = 0.01). The SCN5A expression level was significantly higher and the methylation rate was significantly lower in sections with H558R (N = 10) than those without (0.98 ± 0.14 vs. 0.83 ± 0.19, P = 0.04; 0.7 ± 0.2% vs. 1.6 ± 0.1%, P = 0.004, respectively). In BrS with heterozygous H558R, the A allele mRNA expression was 1.38 fold higher than G allele expression. The SCN5A polymorphism H558R may be a modifier that protects against VF occurrence in BrS. The H558R decreased the SCN5A promoter methylation and increased the expression level in cardiac tissue. An allelic expression imbalance in BrS with a heterozygous H558R may also contribute to the protective effects in heterozygous mutations.

1 May 2006 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
HKHajime Kumagai
Hajime Kumagai
MIMitsuhiro Isaka
Mitsuhiro Isaka
YSYuji Sugawara
Yuji Sugawara
KOKenji Okada
Kenji Okada
KIKatsuhiko Imai
Katsuhiko Imai
TSTaijiro Sueda
Taijiro Sueda
Objective: We investigated whether propofol, a widely used anesthetic, injected into clamped aortic segments quickly attenuated transcranial spinal motor-evoked potential (MEP) amplitudes and protected against spinal cord injury during thoracoabdominal aortic surgery. Methods: Eighteen beagle dogs were divided into three groups (n = 6, each group): group 1 (20 ml of saline, intra-aortic injection), group 2 (1.5 mg/kg of propofol, intravenous injection), and group 3 (1.5 mg/kg of propofol, intra-aortic injection). Aortic cross-clamping was performed for 30 min. In each group, MEP amplitudes were recorded before, during, and after aortic cross-clamping. Tarlov score and histopathological examination were used to evaluate the protective effects of intra-aortic propofol injections. Results: MEP amplitudes in group 3 attenuated to a value that was 60% of the control in just a minute after aortic cross-clamping, but maintained 40% of the control value during aortic cross-clamping. However, MEP amplitudes in groups 1 and 2 gradually attenuated and almost disappeared. Groups 1 and 2 amplitudes were lower than those in group 3, 30 min after aortic cross-clamping (p ≪ 0.001). Twenty-four hours after ischemia, the Tarlov score in group 3 was 3.5 ± 0.5 and was higher than scores from groups 1 and 2, which were 0.5 ± 0.5 and 1.3 ± 1.2 (mean ± SD, p ≪ 0.001, and p ≪ 0.001), respectively. Histopathologically, normal spinal cord motor neurons in group 3 were preserved to a significantly greater extent than in groups 1 and 2 (p = 0.0031, and p = 0.0282, respectively). There was a strong correlation between Tarlov scores at 24 h and the number of normal motor neurons in the anterior horns of spinal cords (r = 0.897; p ≪ 0.001). Conclusions: Intra-aortic propofol injections produce the quick suppression of MEP amplitudes and protect spinal cords from ischemia during aortic cross-clamping.

1 March 2011 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
STShinya Takahashi
Shinya Takahashi
KOKazumasa Orihashi
Kazumasa Orihashi
KIKatsuhiko Imai
Katsuhiko Imai
TMTaketomo Mizukami
Taketomo Mizukami
TTTaiichi Takasaki
Taiichi Takasaki
TSTaijiro Sueda
Taijiro Sueda

1 January 2015 in Circulation Journal
Verified
Journal Article
Open access
NTNaonori Tashiro
Naonori Tashiro
STShinya Takahashi
Shinya Takahashi
TTTaiichi Takasaki
Taiichi Takasaki
KKKeijiro Katayama
Keijiro Katayama
TTTakahiro Taguchi
Takahiro Taguchi
TSTaijiro Sueda
Taijiro Sueda
Postoperative complications after cardiac surgery increase mortality. This study aimed to evaluate the efficacy of cardiopulmonary rehabilitation with adaptive servo-ventilation (ASV) in patients undergoing off-pump coronary artery bypass grafting (OPCAB). A total of 66 patients undergoing OPCAB were enrolled and divided into 2 groups according to the use of ASV (ASV group, 30 patients; non-ASV group, 36 patients). During the perioperative period, all patients undertook cardiopulmonary rehabilitation. ASV was used from postoperative day (POD) 1 to POD5. Hemodynamics showed a different pattern in the 2 groups. Blood pressure (BP) on POD6 in the ASV group was significantly lower than that in the non-ASV group (systolic BP, 112.9±12.6 vs. 126.2±15.8 mmHg, P=0.0006; diastolic BP, 62.3±9.1 vs. 67.6±9.3 mmHg, P=0.0277). The incidence of postoperative atrial fibrillation (POAF) was lower in the ASV group than in the non-ASV group (10% vs. 33%, P=0.0377). The duration of oxygen inhalation in the ASV group was significantly shorter than that in the non-ASV group (5.1±2.2 vs. 7.6±6.0 days, P=0.0238). The duration of postoperative hospitalization was significantly shorter in the ASV group than in the non-ASV group (23.5±6.6 vs. 29.0±13.1 days, P=0.0392). Cardiopulmonary rehabilitation with ASV after OPCAB reduces both POAF occurrence and the duration of hospitalization.

1 January 2011 in Annals of Vascular Diseases
Verified
Journal Article
Open access
KSKatsutoshi Sato
Katsutoshi Sato
KOKazumasa Orihashi
Kazumasa Orihashi
STShinya Takahashi
Shinya Takahashi
TTTaiichi Takasaki
Taiichi Takasaki
TKTatsuya Kurosaki
Tatsuya Kurosaki
TSTaijiro Sueda
Taijiro Sueda
We preoperatively assessed varicose veins by means of computed tomography (CT) with contrast injection in the veins of the lower extremity (CT venography). This paper reports the procedures, results and implications of CT venography from the surgical aspect. A total of 48 legs in 39 patients were examined. Contrast medium was diluted ten-fold and injected into the lower extremity veins, often using a dual route of injection. The images were reconstructed with the volume-rendering method. CT venography clearly visualized the veins with a small amount of contrast medium and facilitated the identification of anatomy that was not suitable for passing the stripper. In addition, CT venography helped identify unusual types of varicose veins or uncommon sites of inflow of small saphenous veins. Such information was helpful for avoiding unexpected vascular injury or for minimizing skin incision. Dual-route injection was beneficial to minimize the blind zones. Doppler ultrasound could be more focused on hemodynamic assessment and determination of incision sites. CT Venography is feasible in all cases of varicose veins. When performed in conjunction with ultrasonography, it appears to facilitate the safe and efficient treatment of various types of varicose veins.